| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/19/2011 | US7982033 Pyrrolotriazine kinase inhibitors |
| 07/19/2011 | US7982030 Synthesis of selenium-derivatized nucleosides, nucleotides, phosphoramidites, triphosphates and nucleic acids |
| 07/19/2011 | US7982028 Oligonucleotides affecting expression of phosphodiesterases |
| 07/19/2011 | US7982004 Nucleic acid and corresponding protein entitled 161P5C5 useful in treatment and detection of cancer |
| 07/19/2011 | US7981939 Application of 2-bromide-isovanillin for the manufacture of a medicament for anti-cancer or/and radiation/chemotherapy sensitization |
| 07/19/2011 | US7981938 Colchicine compositions and methods |
| 07/19/2011 | US7981937 Stable dispersion of DBNPA in viscosified brine |
| 07/19/2011 | US7981936 Crystalline ACAT inhibitor |
| 07/19/2011 | US7981935 Stem cell differentiating agents and uses therefor |
| 07/19/2011 | US7981933 Method for treating an inflammation or lesion caused by a virus |
| 07/19/2011 | US7981932 Salts of alkyl esters of sulfonated dicarboxylic acids and compositions containing same |
| 07/19/2011 | US7981931 Pharmaceutical compositions of short-acting sedative hypnotic agent |
| 07/19/2011 | US7981930 Amantadine or rimantadine, and ribavirin or viramidine, and optionally a neuraminidase inhibitor such as oseltamivir, zanamivir, or peramivir |
| 07/19/2011 | US7981929 Benzofuran derived HIV protease inhibitors |
| 07/19/2011 | US7981928 Chemotherapy method using x-rays |
| 07/19/2011 | US7981927 treatment of disorders and conditions modulated by at least one progesterone or glucocorticoid receptor; 11-(4-Dimethylamino-phenyl)-1-hydroxy-12a-methyl-1-prop-1-ynyl-1,3,4,4a,4b,5,6,9,10,11,12,12a-dodecahydro-2-oxa-chrysen-8-one |
| 07/19/2011 | US7981926 Fluorotaxoids |
| 07/19/2011 | US7981925 Compounds that modulate intracellular calcium |
| 07/19/2011 | US7981924 Thiophene derivatives |
| 07/19/2011 | US7981923 Tetralin and indane derivatives and uses thereof |
| 07/19/2011 | US7981922 Angiotensin I-converting enzyme (ACE) inhibitors |
| 07/19/2011 | US7981921 Crystalline forms of perindopril erbumine |
| 07/19/2011 | US7981920 Addition salts of angiotensin-converting enzyme inhibitors with no donor acids, a process for their preparation and pharmaceutical compositions containing them |
| 07/19/2011 | US7981919 Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators |
| 07/19/2011 | US7981918 Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/19/2011 | US7981917 Methods and compositions for including apoptosis by stimulating ER stress |
| 07/19/2011 | US7981916 Aqueous solutions made with niacinamide and multiple glycolic cosolvents; cyclodextrin and surfactant free; rosacea; nonirritating, nonallergenic |
| 07/19/2011 | US7981915 Methods for modulating PPAR biological activity for the treatment of diseases caused by mutations in the CFTR gene |
| 07/19/2011 | US7981914 Tetrazole-substituted aryl amide derivatives and uses thereof |
| 07/19/2011 | US7981913 Isophthalates as beta-secretase inhibitors |
| 07/19/2011 | US7981912 Indole acetic acids exhibiting CRTH2 receptor antagonism and uses thereof |
| 07/19/2011 | US7981911 Pharmaceutical formulations |
| 07/19/2011 | US7981910 Triazole derivatives as inhibitors of 11-β-hydroxysteroid dehydrogenase-1 |
| 07/19/2011 | US7981909 Use of 1-hydroxy-2-pyridones for the treatment of seborrheic dermatitis |
| 07/19/2011 | US7981908 Compositions and methods for inhibiting gastric acid secretion |
| 07/19/2011 | US7981907 Thio-substituted biarylmethanesulfinyl derivatives |
| 07/19/2011 | US7981906 (2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl-benzofuran-2-carboxamide, novel salt forms, and methods of use thereof |
| 07/19/2011 | US7981905 Pharmaceutical formulations: salts of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-Ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same |
| 07/19/2011 | US7981904 Acetyl CoA carboxylase inhibitors |
| 07/19/2011 | US7981903 2-[2-{phenylamino}-1H-pyrrolo[2,3-D]pyrimidin-4-yl)amino] benzamide derivatives as IGF-1R inhibitors for the treatment of cancer |
| 07/19/2011 | US7981902 Substituted pyrrolo[2,3-d]pyrimidines for selectively targeting tumor cells with FR type receptors |
| 07/19/2011 | US7981901 transdermal formulations comprise a skin penetration enhancer; transdermal formulation, which is topically applied to an area of skin superficial to a carotid artery, a temporal artery, a vertebral artery, or to a tender spot associated with a head |
| 07/19/2011 | US7981900 2-phenyl pyrimidines which are tubulin inhibitors |
| 07/19/2011 | US7981899 Skin aging resistance, wrinkling resistance; (S)-1,4,5,6-tetrahydro-2-methyl-4-pyrimidinecarboxylic acid |
| 07/19/2011 | US7981898 Methods of enhancing mucosal hydration and mucosal clearance by treatment with sodium channel blockers and osmolytes |
| 07/19/2011 | US7981897 Crystal form of (3-cyano-1H-Indo1-7-yl)-[4-(4-fluorophenethyl)piperazin-1-yl]methanone, hydrochloride |
| 07/19/2011 | US7981896 Pyrazoles for the treatment of obesity and other CNS disorders |
| 07/19/2011 | US7981895 Histone deacetylase inhibitor; anticancer agents; antiproliferative agents; antitumor agents; psoriasis; piperazine compound containing a carbamic acid group |
| 07/19/2011 | US7981894 Polymorphic forms of 1-′4-(5-cyanoindol-3-yl) butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride |
| 07/19/2011 | US7981893 Heteroaryl compounds, compositions thereof, and methods of treatment therewith |
| 07/19/2011 | US7981892 Disubstituted phthalazine hedgehog pathway antagonists |
| 07/19/2011 | US7981891 Aurora kinase modulators and method of use |
| 07/19/2011 | US7981890 Phthalazinone derivatives |
| 07/19/2011 | US7981889 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis |
| 07/19/2011 | US7981888 1-oxyalkyl-2-carboxyl-7-nonsubstituted indole derivatives |
| 07/19/2011 | US7981887 Therapeutic compounds |
| 07/19/2011 | US7981886 Antibiotics derivatives |
| 07/19/2011 | US7981885 Compositions for treatment of diseases related to activated lymphocytes |
| 07/19/2011 | US7981884 Process for the preparation of olanzapine |
| 07/19/2011 | US7981883 Substituted spiro-compounds and the use thereof for producing medicaments |
| 07/19/2011 | US7981882 e.g. 7-Chloro-3-(2,2,2-trifluoroacetyl)-6-trifluoromethanesulfonyloxy-2,3,4,5-tetrahydro-1H-benzo[d]azepine; antidepressant, anxiolytic agent; obesity, obsessive/compulsive disorder |
| 07/19/2011 | US7981881 Fused heterocyclic compounds and use thereof |
| 07/19/2011 | US7981880 3-(aminomethyliden) 2-indolinone derivates and their use as cell proliferation inhibitors |
| 07/19/2011 | US7981879 HIV integrase inhibitors |
| 07/19/2011 | US7981878 Tumor treatment with gliotoxin derivatives |
| 07/19/2011 | US7981877 Stabilized steroid composition and method for its preparation |
| 07/19/2011 | US7981876 Polymorphic and amorphous salt forms of squalamine dilactate |
| 07/19/2011 | US7981875 Treating pancreatic cancer by administering cardenolide uscharin extracted from Calotropis procera plants |
| 07/19/2011 | US7981874 Phosphorus derivatives as histone deacetylase inhibitors |
| 07/19/2011 | US7981873 Use within transplantation surgery |
| 07/19/2011 | US7981871 Modified macromolescules and associated methods of synthesis and use |
| 07/19/2011 | US7981861 Method of performing angioplasty with a GLP-1 molecule |
| 07/19/2011 | US7981676 Method for transfer of molecular substances with prokaryotic nucleic acid-binding proteins |
| 07/19/2011 | US7981631 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment and monitoring of periodontal diseases |
| 07/19/2011 | US7981598 Preventive/remedy for respiratory diseases |
| 07/19/2011 | US7981596 Tissue preservation with a salt solution isotonic with interstitial fluids |
| 07/19/2011 | US7981460 Substituted benzyl ester derivative and use thereof |
| 07/19/2011 | US7981449 Production process of purified green tea extract |
| 07/19/2011 | US7981445 Compositions and methods for preparation of poorly water soluble drugs with increased stability |
| 07/19/2011 | US7981443 Administration of therapeutically effective amount of topiramate over sleep period of patient |
| 07/19/2011 | US7981439 Methods and compositions for deterring abuse of drugs susceptible to abuse and dosage forms thereof |
| 07/19/2011 | US7981437 Indanyl- and tetrahydronaphthyl-amino-azoline compounds for combating animal pests |
| 07/19/2011 | US7981436 gels based on guanosine hydrazide derivatives, used as a carriers or for delivery of flavors, fragrances, insect attractants or repellents, bactericides, fungicides, pharmaceuticals or agrochemicals |
| 07/19/2011 | US7981429 Influenza hemagglutinin and neuraminidase variants |
| 07/19/2011 | US7981421 Combinations of antibodies selective for DR5 and other therapeutic agents |
| 07/19/2011 | US7981420 Therapeutic use of antibodies directed against repulsive guidance molecule (RGM) |
| 07/19/2011 | US7981413 Using cell surface adhesion proteins specific immunoglobulin to target therapeutics to tumorous; immunodiagnostics; immunotherapy |
| 07/19/2011 | US7981408 Method of preserving food using antimicrobial packaging |
| 07/19/2011 | US7981406 Compositions for accelerating the production of collagen-containing proteins |
| 07/19/2011 | US7981401 Diuretic aerosols and methods of making and using them |
| 07/19/2011 | US7981398 PEGylation by the dock and lock (DNL) technique |
| 07/19/2011 | CA2690488A1 Pharmaceutical formulations of naproxen for soft gel encapsulation and combinations thereof |
| 07/19/2011 | CA2658116C 1- (-d-glycopyranosyl) - 3 - (4-cyclopropylphenylmethyl) - 4 - halogeno indole derivatives and use thereof as sglt inhibitors |
| 07/19/2011 | CA2647346C Malate salts, and polymorphs of (3s,5s)-7-[3-amino-5-methyl-piperidinyl]-1-cyclopropyl-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid |
| 07/19/2011 | CA2637774C Nucleosides with anti-hepatitis b virus activity |
| 07/19/2011 | CA2634702C Crystalline and pure modafinil, and process of preparing the same |
| 07/19/2011 | CA2614700C Medicinal composition containing ginseng secondary glycosides, its preparation method and application |
| 07/19/2011 | CA2609733C 6,7-unsaturated-7-carbamoyl-substituted morphinan derivative |
| 07/19/2011 | CA2599415C Stable micronized candesartan cilexetil and methods for preparing thereof |
| 07/19/2011 | CA2586011C Tricyclic pyrazole derivatives as cannabinoid receptor modulators |